Antimicrobial resistance among uropathogens responsible for community-acquired urinary tract infections in an Italian community

Journal of Chemotherapy

Volumn 20, Issue 6, 2008, Pages 721-727

  Miragliotta, Giuseppe ^a   Di Pierro, M N ^a   Miragliotta, L ^a   Mosca, A ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Associated resistance; Cross resistance; Urinary tract infections; Uropathogens

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIMENTIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMMUNICABLE DISEASE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; ITALY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT; PROTEUS MIRABILIS; URINARY TRACT INFECTION;

EID: 59349087508     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.6.721     Document Type: Article

References (19)

1. Car J. Urinary tract infections in women: diagnosis and management in primary care. BMJ 2006; 332(7533): 94-7.
2. McNulty CA, Richards J, Livermore DM, et al. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother 2006; 58 (5):1000-8.
3. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 2000; 19 (2):112-7.
4. Manges AR, Natarajan P, Solberg OD, Dietrich PS, Rilev LW. The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiol Infect 2006; 134 (2): 425-31.
5. Kahan NR, Chinitz DP, Waitman DA, Dushnitzky D, Kahan E, Shapiro M. Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Istrael: another lost treatment option? Ann Pharmacother 2006; 40 (12): 2223-7.
6. Clinical and Laboratory Standard Institute (formerly National Committee for Clinical Laboratory Standards). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow aerobically -M7-A5 (2002) and M100-S12 (2004), Wayne, PA, NCCLS, and M100-S15 (2005), Wayne, PA, CLSI.
7. Struelens MJ. The problem of resistance. In: Finch RG, Greenwood D, Norrby SR, Whitley RJ, eds. Antibiotic and Chemotherapy. Philadelphia: Churchill Livingstone, 2003; 25-47.
8. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 Suppl 2:S146-55.
9. Kunin CM. Urinary tract infections in females. Clin Infect Dis 1994; 18 (1):1-10.
10. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999: 281 (8):736-8.
11. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001; 33 (1): 89-94.
12. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11 (3): 551-81.
13. Kahlmeter G, Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 2003; 52 (1): 128-31.
14. Garcia Garcia MI, Munoz Bellido JL, Garcia Rodriguez JA. In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004). J Chemother 2007; 19 (3): 263-70.
15. Zhanei GG, Hisanaga TL, Laing NM et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006; 27 (6): 468-75.
16. Honderlick P, Cahen P, Gravisse J, Vignon D. Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006? Pathol Biol (Paris) 2006; 54 (8-9): 462-6
17. Fadda G, Nicoletti G, Schito GC, Tempera G. Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines. J Chemother 2005; 17 (3): 251-7.
18. Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003; 17 (2): 243-59.
19. Galatti L, Sessa A, Mazzaglia G et al. Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study. J Antimicrob Chemother 2006; 57 (3): 551-6.